Intrepid was proud to sponsor and participate in the second annual Autism Investor Summit, which brought together many of the country’s fastest-growing autism services businesses with leading private equity investors… Read more »
2019 produced another record year for M&A activity in the fertility services sector as financial sponsors and strategic acquirers alike continued making moves to develop and consolidate the highly fragmented… Read more »
As we welcome in the New Year and a new decade, one constant remains in the healthcare industry – the deal community’s annual convergence in San Francisco’s Union Square each… Read more »
With the magic of the holiday season upon us, we donned our festive best to celebrate a transformative year for Intrepid. After eight thrilling years of growth, we joined MUFG,… Read more »
Despite all the geopolitical noise domestically and around the world, the stock market continues to soar to new highs and private equity and debt markets are following suit. If you or… Read more »
Private debt and equity groups continue to raise new funds and compete aggressively to find deals. At the same time, concern about a potential turn in the market is leading… Read more »
Intrepid announced today that it acted as the exclusive financial advisor to Cicoil, LLC (Cicoil) in connection with its acquisition by TPC Wire & Cable Corp. (TPC), a portfolio company… Read more »
Intrepid announced today the launch of its Food, Beverage & Agriculture practice which will be led by industry veteran Michael Seccuro, Managing Director and Head of the Food, Beverage &… Read more »
January 1, 2019, marked a new chapter in Intrepid’s evolution. We took a quantum leap in positioning our firm for profound growth. The changes were many—we added talent and capabilities… Read more »
In July 2019, Exact Sciences (NASDAQ: EXAS) announced it would acquire Genomic Health (NASDAQ: GHDX) for $2.8 billion in cash and stock. This was one of the largest M&A deals… Read more »
